Next Article in Journal
Follow-Up Care After Metabolic Surgery—A Prospective Study in the North-Eastern Region of Romania
Previous Article in Journal
Prevalent Distribution of Conscious Processes on Either Side of the Brain
 
 
Journal of Mind and Medical Sciences is published by MDPI from Volume 12 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Valparaiso University (ValpoScholar).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Best Therapeutic Practices in the Management of Obstetric Sepsis

by
Gabriel Petre Gorecki
1,2,
Oana Denisa Balalau
3,4,*,
Diana Elena Comandasu
3,5,
Anca Daniela Stanescu
3 and
Dana Rodica Tomescu
3,6
1
Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania
2
CF2 Clinical Hospital, Department of Anesthesia and Intensive Care, Bucharest, Romania
3
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
4
St. Ioan Hospital, Bucur Maternity, Bucharest, Romania
5
Prof. Dr. Panait Sarbu Hospital, Bucharest, Romania
6
Fundeni Clinical Institute, Department of Anesthesia and Intensive Care, Bucharest, Romania
*
Author to whom correspondence should be addressed.
J. Mind Med. Sci. 2023, 10(2), 304-311; https://doi.org/10.22543/2392-7674.1436
Submission received: 5 May 2023 / Revised: 17 June 2023 / Accepted: 26 June 2023 / Published: 25 October 2023

Abstract

:
Background. Physiological changes that occur during pregnancy make maternal sepsis a difficult condition to diagnose and treat, still having a fairly high mortality rate. Consequently, an early diagnosis and prompt therapeutic management of sepsis can significantly decrease mortality. The purpose of this study is to review literature data that present current practices in the management of obstetric sepsis. Methods. To collect the data required for the study, we performed a search of published articles in the PubMed and Google Scholar databases related to obstetric sepsis. Research paper articles from the period 2012–2022 were included in the analysis. In addition, 145 articles from the period 2012–2022 were evaluated, with the aim of finding out in which situations the risk of maternal death is higher. Thus, the analysis included a total number of 151 articles, which were divided into two distinct stages. Results. The risk of maternal death is higher among patients with the human immunodeficiency virus (HIV), followed by Escherichia coli, genital tract infection, cancer, drug users and in the case of patients with chronic liver disease. Conclusions. After analyzing the data, we found that prompt and focused antibiotic therapy as well as fluid resuscitation are essential to increase the chances of survival of these patients.

Introduction

Worldwide, between 20-40% of maternal deaths are caused by sepsis during the peripartum period [1,2,3]. Due to the physiological changes that occur during pregnancy, maternal sepsis is a condition with a high mortality rate, which becomes quite difficult to diagnose, thus leading to delays in the application of therapeutic protocols aimed at reducing mortality [4,5,6].
Post-abortion sepsis can occur following a miscarriage, a surgical abortion or even the consequence of an illegal abortion. It is usually caused by an ascending infection that leads to endometritis or parametritis, and which later progresses to sepsis [7,8,9].
Validated diagnostic criteria for maternal sepsis and septic shock may reduce their impact on maternal health globally. Unfortunately, the overlapping manifestations of the physiological adaptations that occur during pregnancy and the signs and symptoms of infection and sepsis can cause delays in both diagnosis and treatment [10,11].
When signs of sepsis are not recognized and treated promptly, they can progress rapidly in pregnant women or women who have recently given birth, leading to life- threatening pathophysiological imbalances [12].
Infertility, fetal death, chronic pelvic inflammatory disease, organ failure, bilateral tubal blockage, chronic pelvic pain are major morbidities associated with obstetric sepsis. Therefore, early detection and prompt therapeutic action are essential for a successful outcome.
For the identification and prognosis of patients with sepsis, machine learning prediction models outperformed already used sepsis scoring systems, including SOFA, SIRS, qSOFA, and MEWS. Using machine learning algorithms to predict patients with sepsis could help doctors actively monitor and take preventive measures to improve patients’ conditions [13].

Materials and Methods

The aim of this study is to review the studies that present the practices used in the management of obstetric sepsis. The Google Scholar database was used, and for obstetric sepsis we obtained 224,000 articles. To facilitate the analysis, we decided to investigate the articles from the period 2012-2022, obtaining a number of 17,900 articles. The PubMed database was also queried, thus generating 261 articles for obstetric sepsis (period 2012–2022). In the end, we had to study a total of 18,161 articles.
We proposed to analyze in the first stage 20 articles according to the following criteria: full paper articles, not be duplicated, research paper type, a large number of citations, publication period starting with 2012. From the 20 articles we managed to extract only 6 that corresponded to the topic of analysis. In the second stage, we set out to analyze 250 articles from the period 2012-2022 in which we wanted to find out in which situations the risk of maternal death is higher. The selection of articles was made on the same principle as in the first stage. We were able to retrieve 145 articles from the Google Scholar. In total, we analyzed 151 articles from the PubMed database and from the Google Scholar search engine, by Prisma Model, as presented in Figure 1.

Results

We propose to present 6 articles following the analysis process: authors and year of publication, purpose, results, conclusions and limitations. Thus, we obtained the following results from the review process, which are presented in the Table 1, Table 2, Table 3, Table 4, Table 5 and Table 6.
The study by Albright et al. (2014) showed that until that time, no scoring system had been developed that took into account the normal physiological changes of pregnancy. This is also the reason why morbidity and mortality in a pregnant population has been accurately predicted. So S.O.S. became a modified sepsis scoring system for pregnancy-specific physiologic changes that was able to identify pregnant and postpartum patients at risk for sepsis intensive care unit admission within 48 hours of emergency department presentation [14].
The study by Aarvold et al. (2017) contradicts the study by Albright et al. (2014) who say that the best predictor of mortality in the obstetric population is the MODS score. This score was significantly better than the physiology- based SAPS II (Simplified Acute Physiology Score) and APACHE II (Acute Physiology and Chronic Health Evaluation) scores and the obstetric-specific SOS score. On the other hand, MODS and SOFA scores performed better in the obstetric population, suggesting that perhaps an organ-based system is more accurate. This is because of poorer outcomes in patients with multiple organ dysfunction than those in whom organ function is preserved [15].
The study by Leisman et al. (2017) showed that adherence to the 3-hour bundle is sufficient to improve clinical outcomes for patients without relying on invasive monitoring or complex physiological endpoints. We intend to carry out further analysis for the following studies [16].
The study by Ferrer et al. (2014) showed that for the increased risk associated with delay there was a linear increase in the risk of mortality for each hour of delay in antibiotic administration from the first to the sixth hour after patient identification. In other words, sepsis is a time- dependent condition and must be recognized as an urgent situation that requires an immediate response [17].
In the study conducted by Holanda et al. (2020) provided a better understanding of the factors associated with death resulting from sepsis in obstetric patients with the aim of identifying prognostic factors and optimizing management [18].
The study by Al-Ostad et al. (2015) showed that black women, older than 35 years, and smokers were more likely to experience maternal sepsis. An association has also been found between maternal sepsis and diabetes mellitus, cardiovascular disease, eclampsia, hysterectomy, puerperal infection, preterm birth, postpartum hemorrhage, transfusion, and chorioamnionitis [19].

Discussions

The analysis of this study included a sample of 29,952 patients, 3 cohorts, and a database of 5 million births from 6 specialty studies.
The analyzed studies recommended the following therapeutic practices for the management of obstetric sepsis. The S.O.S. sepsis scoring system (Obstetric Sepsis Score) was able to identify pregnant and postpartum patients at risk of admission to the intensive care unit for sepsis within 48 hours of presentation to the emergency department.
Disease severity scores based on organ failure, such as the MODS (Multiple Organ Dysfunction Score), have been shown to be equally effective in obstetric and nonobstetric (age- and sex-equivalent) populations.
Adherence to the 3-hour protocol was associated with improved survival and significant cost savings.
The administration of antibiotics must be done as soon as possible to avoid the death of the patient.
The selection of articles was made according to the following criteria: complete articles, not to be duplicated, the type of research paper, a large number of citations, and the publication period starting from 2012.
For patients with suspected sepsis, prompt and focused antibiotic therapy and fluid resuscitation are essential for the survival of these cases [20,21].
The study by Bowyer et al. (2017) presents a series of diagnostic and therapeutic indications related to general anesthesia. Thus, the study claims that the septic obstetric patient frequently exhibits hemodynamic instability and has a higher-than-normal pregnancy-related metabolic oxygen requirement. For the administration of general anesthesia, practical considerations include for the airways avoiding delayed gastric emptying, and thus avoiding an increased risk of gastric reflux followed by aspiration. It is recommended that women be premedicated with combined prophylaxis with antacid antihistamines (effervescent ranitidine, 150 mg). A rapid induction sequence is also recommended. For the pulmonary ventilation process, it would be advisable to provide patients with adequate pre- oxygenation before induction of anesthesia. In these patients there is a reduced residual functional capacity, which implies a limitation of the interrelationship between ventilation and perfusion. Consequently, the use of therapeutic ventilation strategies is recommended to maintain adequate oxygenation to minimize possible subsequent lung injury [22].
Regarding the circulatory system, consideration should be given to avoiding aortocaval compression by lateral tilting of the uterus, ensuring adequate fluid resuscitation, including appropriate use of blood products and, if necessary, inotropic support. Alpha adrenergic agonists (especially noradrenaline) are the agents of choice for maintaining uteroplacental flow.
Rapid and effective fluid resuscitation is essential to stabilize septic shock or sepsis-induced tissue hypoperfusion. Given the critical status of this medical emergency, early fluid resuscitation should begin as soon as the patient is diagnosed with sepsis, hypotension, or elevated lactate, and be completed within three hours of diagnosis. The minimum recommended amount of intravenous crystalloid for such therapy is 30 ml/kg according to current guidelines [23].
Effective treatment of sepsis was found to require aggressive resuscitation protocols involving adequate control of the source of sepsis, appropriate antibiotic drugs, and adequate support for failing organs. Therefore, delay in starting appropriate antibiotic treatment increases the risk of death in obstetric patients with sepsis [24,25].
We also aimed to analyze which studies are at risk of bias. Thus, 145 articles from 2012-2022 were analyzed, in which we intended to identify in which situations the risk of maternal death is higher.
Thus, the largest proportion of this maternal risk (24%) is found in patients with the human immunodeficiency virus (HIV), 29% in patients with Escherichia coli, 17% in patients with genital tract infection, 14% in patients with cancer, 14 % in the case of drug users, and 12% in the case of patients with chronic liver disease (Figure 2).
HIV infection may contribute to an increased risk of postpartum infection and infection-related mortality [26].
About 13% of cases require admission to intensive care, so there is a 2.9-fold risk of preterm birth and a 5.8- fold risk of perinatal mortality. In the case of infection of the genital tract for the first and second trimester, fetal loss occurs. The most prevalent organisms are E. coli and group B streptococcus, although the most virulent organisms are E. coli associated with preterm sepsis and group A streptococcus associated with postpartum sepsis [27,28,29].
Women who give birth by caesarean section are more prone to severe sepsis, while women who give birth vaginally are more prone to infection with group A streptococcus. On the other hand, women already infected with group A streptococcus have a higher risk of progression to septic shock, in contrast to women infected with another infectious agent [30,31,32].
The study by Balki et al. (2022) also included among the risks: stillbirths, artificial rupture of membranes, retained products of conception, as well as surgical procedures (hysterectomy, cervical cerclage, dilatation and curettage) and obstetric conditions (postpartum hemorrhage, preeclampsia/eclampsia, and placental abruption) [33].
The study by Shields et al. (2023) presents a series of recommendations on how to manage sepsis during pregnancy and in the postpartum period. Thus, if sepsis and septic shock are medical emergencies, treatment and resuscitation should begin as soon as possible. In the case of severe organ damage in pregnant patients due to an infectious process, the diagnosis of sepsis must be made as quickly as possible, while broad-spectrum antibiotics must be administered (to any pregnant woman suspected of having sepsis) within a maximum of 1 hour. Also, requirements include obtaining cultures (blood, urine, respiratory, etc.) and serum lactate levels in pregnant or postpartum women with suspected or identified sepsis, and early control of the source of sepsis should be completed as soon as possible. Early administration of 1-2 L of crystalloid solutions is also recommended in sepsis complicated by arterial hypotension or suspected organ hypoperfusion [34,35,36,37,38,39]. Another recommendation concerns the use of norepinephrine as a first-line vasopressor during pregnancy and the postpartum period in sepsis with persistent hypotension and/or hypoperfusion, in addition to fluid resuscitation [36,37,38,39,40]. Therefore, protocols to improve early diagnosis and effective therapeutic management may help reduce the incidence and consequences of maternal sepsis during labor and delivery.

Conclusions

Maternal deaths due to severe sepsis are generally caused by late presentation to the doctor, which further leads to delay in diagnosis and treatment.
The obstetric-specific S.O.S. score has been shown to have a poor predictive value for the assessment of mortality in obstetric septic shock.
Establishing an early diagnosis and rapid multidisciplinary therapeutic management (obstetrician, neonatologist and intensive care physician and anesthetist) are essential for the patient’s prognosis.
Transfer to intensive care is necessary if the patient is hemodynamically unstable and requires vasopressor support, requires mechanical ventilation or presents an altered level of consciousness, hemodialysis, multiple organ failure, or hypothermia.

Compliance with ethical standards

Any aspect of the work covered in this manuscript has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. Informed consent was obtained from all subjects involved in the study.

Conflict of interest disclosure

There are no known conflicts of interest in the publication of this article. The manuscript was read and approved by all authors.

References

  1. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020, 395, 200–211. [Google Scholar] [CrossRef]
  2. Giouleka S, Boureka E, Tsakiridis I, et al. Sepsis in Pregnancy and the Puerperium: A Comparative Review of Major Guidelines. Obstet Gynecol Surv. 2023, 78, 237–248. [Google Scholar] [CrossRef]
  3. Jury I, Thompson K, Hirst JE. A scoping review of maternal antibiotic prophylaxis in low- and middle- income countries: Comparison to WHO recommendations for prevention and treatment of maternal peripartum infection. Int J Gynaecol Obstet. 2021, 155, 319–330. [Google Scholar] [CrossRef]
  4. Escobar MF, Echavarría MP, Zambrano MA, et al. Maternal sepsis. Am J Obstet Gynecol MFM. 2020, 2, 100149. [Google Scholar] [CrossRef]
  5. Lucas DN, Robinson PN, Nel MR. Sepsis in obstetrics and the role of the anaesthetist. Int J Obstet Anesth. 2012, 21, 56–67. [Google Scholar] [CrossRef]
  6. Abutheraa N, Grant J, Mullen AB. An Observational Cohort Study Evaluating Antimicrobial Use in Peripartum Sepsis: A Tendency towards Overdiagnosis? Pharmacy (Basel). 2020, 8, 211. [Google Scholar] [CrossRef]
  7. Lapinsky, SE. Obstetric infections. Crit Care Clin. 2013, 29, 509–520. [Google Scholar] [CrossRef]
  8. Brizuela V, Cuesta C, Bartolelli G, et al. Availability of facility resources and services and infection-related maternal outcomes in the WHO Global Maternal Sepsis Study: a cross-sectional study. Lancet Glob Health. 2021, 9, e1252–e1261. [Google Scholar] [CrossRef]
  9. Bonet M, Nogueira Pileggi V, Rijken MJ, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017, 14, 67. [Google Scholar] [CrossRef]
  10. Filetici N, Van de Velde M, Roofthooft E, Devroe S. Maternal sepsis. Best Pract Res Clin Anaesthesiol. 2022, 36, 165–177. [Google Scholar] [CrossRef]
  11. Stanescu AD, Balalau DO, Ples L, Paunica S, Balalau C. Postpartum depression: Prevention and multimodal therapy. J Mind Med Sci. 2018, 5, 163–168. [Google Scholar] [CrossRef]
  12. Brown KN, Arafeh JM. Obstetric Sepsis: Focus on the 3-Hour Bundle. J Perinat Neonatal Nurs. 2015, 29, 213–221. [Google Scholar] [CrossRef]
  13. Islam MM, Nasrin T, Walther BA, et al. Prediction of sepsis patients using machine learning approach: A meta-analysis. Comput Methods Programs Biomed. 2019, 170, 1–9. [Google Scholar] [CrossRef]
  14. Albright CM, Ali TN, Lopes V, et al. The Sepsis in Obstetrics Score: a model to identify risk of morbidity from sepsis in pregnancy. Am J Obstet Gynecol. 2014, 211, 39.e1–39.e398. [Google Scholar] [CrossRef]
  15. Aarvold AB, Ryan HM, Magee LA, von Dadelszen P, Fjell C, Walley KR. Multiple Organ Dysfunction Score Is Superior to the Obstetric-Specific Sepsis in Obstetrics Score in Predicting Mortality in Septic Obstetric Patients. Crit Care Med. 2017, 45, e49–e57. [Google Scholar] [CrossRef]
  16. Leisman DE, Doerfler ME, Ward MF, et al. Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts. Crit Care Med. 2017, 45, 395–406. [Google Scholar] [CrossRef]
  17. Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014, 42, 1749–1755. [Google Scholar] [CrossRef]
  18. Holanda AMC, de Amorim MMR, Bezerra SMB, Aschoff LMS, Katz L. Risk factors for death in patients with sepsis admitted to an obstetric intensive care unit: A cohort study. Medicine (Baltimore). 2020, 99, e23566. [Google Scholar] [CrossRef]
  19. Al-Ostad G, Kezouh A, Spence AR, Abenhaim HA. Incidence and risk factors of sepsis mortality in labor, delivery and after birth: population-based study in the USA. J Obstet Gynaecol Res. 2015, 41, 1201–1206. [Google Scholar] [CrossRef]
  20. Shields A, de Assis V, Halscott T. Top 10 Pearls for the Recognition, Evaluation, and Management of Maternal Sepsis. Obstet Gynecol. 2021, 138, 289–304. [Google Scholar] [CrossRef]
  21. Loghin MG, Gorescki PG, Sima RM, Pleș L, Balan DG, et al. The obstetrical management of HIV-positive pregnancy. J Mind Med Sci. 2022, 9, 111–117. [Google Scholar] [CrossRef]
  22. Bowyer L, Robinson HL, Barrett H, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy. Aust N Z J Obstet Gynaecol. 2017, 57, 540–551. [Google Scholar] [CrossRef]
  23. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018, 44, 925–928. [Google Scholar] [CrossRef]
  24. Woodd SL, Montoya A, Barreix M, et al. Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS Med. 2019, 16, e1002984. [Google Scholar] [CrossRef]
  25. Iancu G, Serban D, Badiu CD, et al. Tyrosine kinase inhibitors in breast cancer (Review). Exp Ther Med. 2022, 23, 114. [Google Scholar] [CrossRef]
  26. Bebell LM, Ngonzi J, Siedner MJ, et al. HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda. AIDS Care. 2018, 30, 943–953. [Google Scholar] [CrossRef]
  27. Knowles SJ, O’Sullivan NP, Meenan AM, Hanniffy R, Robson M. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG. 2015, 122, 663–671. [Google Scholar] [CrossRef]
  28. Serban D, Badiu DC, Davitoiu D, et al. Systematic review of the role of indocyanine green near-infrared fluorescence in safe laparoscopic cholecystectomy (Review). Exp Ther Med. 2022, 23, 187. [Google Scholar] [CrossRef]
  29. Wilkie GL, Prabhu M, Ona S, et al. Microbiology and Antibiotic Resistance in Peripartum Bacteremia. Obstet Gynecol. 2019, 133, 269–275. [Google Scholar] [CrossRef]
  30. Acosta CD, Kurinczuk JJ, Lucas DN, et al. Severe maternal sepsis in the UK, 2011-2012: a national case- control study. PLoS Med. 2014, 11, e1001672. [Google Scholar] [CrossRef]
  31. Polprasarn P, Thongwon T. Modified Early Obstetric Warning Criteria Predict Maternal Morbidity in the Immediate Postpartum Period: A Case-Control Study. Nurs Womens Health 2023. [Google Scholar] [CrossRef]
  32. Attia Hussein Mahmoud H, Parekh R, Dhandibhotla S, et al. Insight Into Neonatal Sepsis: An Overview. Cureus. 2023, 15, e45530. [Google Scholar] [CrossRef]
  33. Balki I, Baghirzada L, Walker A, Lapinsky S, Balki M. Incidence, morbidity, and associated factors for sepsis in women hospitalized for delivery: a nationwide retrospective observational population-based study in Canada. Can J Anaesth. 2022, 69, 298–310. [Google Scholar] [CrossRef]
  34. Bălălău OD, Bacalbașa N, Stănescu DA. Cesarean scar defects and placental abnormalities: a three-year survey study. J Mind Med Sci. 2017, 4, 156–162. [Google Scholar] [CrossRef]
  35. Pohl N, Bauer ME, Pancaro C. Characteristics and Outcomes of Obstetric Sepsis by Three Sets of Clinical Diagnostic Criteria - a Retrospective Study. Am J Perinatol 2023. [Google Scholar] [CrossRef]
  36. Olaru OG, Stanescu AD, Raduta C, et al. Caesarean section versus vaginal birth in the perception of woman who gave birth by both methods. J Mind Med Sci. 2021, 8, 127–132. [Google Scholar] [CrossRef]
  37. Guo L, Han W, Su Y, et al. Perinatal risk factors for neonatal early-onset sepsis: a meta-analysis of observational studies. J Matern Fetal Neonatal Med. 2023, 36, 2259049. [Google Scholar] [CrossRef]
  38. Wieser MN, Gourounti K, Sarantaki A. Modes of birth and their impact on the psychological and physical health of women. J Mind Med Sci. 2021, 8, 1–4. [Google Scholar] [CrossRef]
  39. Society for Maternal-Fetal Medicine (SMFM), Shields AD, Plante LA, Pacheco LD, Louis JM; SMFM Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis. Am J Obstet Gynecol. 2023, 229, B2–B19. [Google Scholar] [CrossRef]
  40. He D, Zhang L, Hu H, et al. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database. Am J Emerg Med. 2023, 69, 188–194. [Google Scholar] [CrossRef]
Figure 1. Identification and selection of studies analyzed
Figure 1. Identification and selection of studies analyzed
Jmms 10 00033 g001
Figure 2. The risk of maternal death.
Figure 2. The risk of maternal death.
Jmms 10 00033 g002
Table 1. Results obtained by Albright et al. (2014) [14].
Table 1. Results obtained by Albright et al. (2014) [14].
PurposeA retrospective cohort study of pregnant and postpartum patients with suspected SIRS or sepsis was performed.
Number of subjects included850 women were included.
Inclusion criteriaWomen at high risk of sepsis were included. Only those who had blood cultures or a flu swab sent to the clinical laboratory were included.
Blood cultures or an influenza swab were used as surrogate markers for a patient presenting with signs or symptoms of sepsis.
ResultsOf the 850 hospitalized patients. 9 were admitted to the intensive care unit (1.1%), 32 of the women were in the telemetry unit (3.8%), and none died.
The most common diagnosis at presentation was influenza-like illness (ILI) (60.4%), followed by viral non-respiratory syndrome (11.1%), pyelonephritis (5.3%),
endometritis (4.5%), pneumonia (2.4%),
mastitis (1.2%), chorioamnionitis (0.7%) and septic abortion (0.6%).
ConclusionsA sepsis scoring system of the S.O.S. type (Obstetric Sepsis Score) was used for all pregnancy-specific physiological changes.
This system was able to identify pregnant and postpartum patients at risk of admission to the intensive care unit for sepsis within 48 hours of presentation to the emergency department.
LimitationsThe study is retrospective and was conducted at only one institution.
Patients included were only those with signs of sepsis in the emergency department and not those who became septic after admission.
Table 2. Results obtained by Aarvold et al. (2017) [15].
Table 2. Results obtained by Aarvold et al. (2017) [15].
PurposeThe study aimed to analyze five mortality prediction scores (one obstetric-based and four general) in the septic obstetric population and compare them with a nonobstetric septic control group.
Number
of subjects included

797 women were included.
Inclusion criteriaThe women were in the 16-50 age group with a diagnosis or suspicion of sepsis.
All pregnant and postpartum patients up to 6 weeks postpartum were included.
An age- and sex-matched non-obstetric control population was drawn from a single-center critical care population.
ResultsThe Obstetrics Sepsis Score, designed specifically for sepsis in obstetric populations, was no better than overall severity of illness scoring systems.
Additionally, the Sepsis in Obstetric Performance Score was not different in an obstetric sepsis population compared to a nonobstetric sepsis population.
ConclusionsThe obstetric-specific S.O.S. (Septic Obstetric Patients) score has been shown to have poor predictive value for mortality in both septic obstetric and nonobstetric populations.
Also, disease severity scores based on organ failure, such as the MODS (Multiple Organ Dysfunction Score), are superior to the obstetric-specific SOS score in an obstetric population. Indeed, the MODS score performs equally well in obstetric and nonobstetric (age- and sex- equivalent) populations.
LimitationsEven though there was a large number of patients in the databases, the final figures of the septic cohort are small and therefore there is a significant geographical variation in the mortality figures.
Table 3. Results obtained by Leisman et al. (2017) [16].
Table 3. Results obtained by Leisman et al. (2017) [16].
PurposeDetermining mortality and costs associated with adherence to an aggressive 3-hour sepsis bundle versus nonadherence to a greater or equal bundle element for patients with severe sepsis and septic shock.
Number of subjects includedCohort 1: five tertiary and six community hospitals.
Cohort 2: single tertiary, academic medical center.
Cohort 3: five tertiary and four community hospitals.
Inclusion criteriaConsecutive sample of all patients with severe sepsis and septic shock (defined as: infection, ≥ 2 systemic inflammatory response syndrome and hypoperfusion organ dysfunction) identified through a quality initiative.
The exposure was full 3-hour bundle compliance. Bundle elements are as follows: 1) blood cultures before antibiotics; 2) parenteral antibiotics administered less than or equal to 180 minutes from greater than or equal to two systemic inflammatory response syndrome `and` lactate ordered, or less than or equal to 60 minutes from `time- zero`, whichever occurs earlier; 3) dairy result available less than or equal to 90 minutes postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 minutes from `time zero`.
ResultsCohort 1: 5,819 total patients; 1,050
(18.0%) bundle compliant. Mortality: 604
(22.6%) versus 834 (26.5%); CI, 0.9–
7.1%; adjusted odds ratio, 0.72; CI, 0.61– 0.86; p value is less than 0.001.
Cohort 2: 1,697 total patients; 739
(43.5%) bundle compliant. Mortality: 99
(13.4%) versus 171 (17.8%), CI, 1.0–
7.9%; adjusted odds ratio, 0.60; CI, 0.44– 0.80; p value is equal to 0.001. Mean costs: $14,845 versus $20,056; CI, –
$4,798 to –5,624; adjusted β, –$2,851; CI, –$4,880 to –822; p value is equal to 0.006. Cohort 3: 7,239 total patients; 2,115
(29.2%) bundle compliant. Mortality: 383
(18.1%) versus 1,078 (21.0%); CI, 0.9–
4.9%; adjusted odds ratio, 0.84; CI, 0.73– 0.96; p value is equal to 0.013. Mean costs: $17,885 versus $22,108; CI, –
$2,783 to –5,663; adjusted β, –$1,423; CI, –$2,574 to –272; p value is equal to 0.015.
ConclusionsIn three independent cohorts, 3-hour bundle compliance was associated with improved survival and cost savings.
LimitationsCompliant groups had lower frequency of some comorbidities and organ dysfunction criteria.
Nonexperimental findings cannot show causality.
Table 4. Results obtained by Ferrer et al. (2014) [17].
Table 4. Results obtained by Ferrer et al. (2014) [17].
PurposeThe aim of the study was to analyze the relationship between the timing of antibiotic administration and mortality.
Number of subjects includedOne hundred sixty-five ICUs in Europe, the United States, and South America.
Inclusion criteria28,150 patients with severe sepsis and septic shock were entered.
ResultsAfter diagnosis of sepsis, a total of 17,990 people were given antibiotics and then included in the analysis. The cohort as a whole had an in-hospital death rate of 29.7%.
There was a statically significant increase in the probability of death associated with the number of hours of delay in first antibiotic administration.
In-hospital mortality adjusted for severity (sepsis severity score), source of ICU admission (emergency department, ward, versus ICU), and geographic region increased steadily after 1 hour of time to antibiotic administration. Results were similar in patients with severe sepsis and septic shock, regardless of the number of organ failure.
ConclusionsDelay in first antibiotic administration was associated with increased in-hospital mortality.
LimitationsThe appropriateness of antibiotic therapy in this patient population has not been analyzed.
The study did not look at the reasons for the delay or the cause of the delay in antibiotic administration.
Table 5. Results obtained by Holanda et al. (2020) [18].
Table 5. Results obtained by Holanda et al. (2020) [18].
PurposeThe study aimed to analyze the risk factors for death in patients with sepsis admitted to the obstetric intensive care unit of a hospital.
Number
of subjects included

155 patients
Inclusion criteria155 patients with sepsis
Results14.2% (n= 22) died. Risk factors for death were septic shock at the time of hospitalization (relative risk [RR]= 3.45; 95% confidence interval [CI]: 1.64–7.25), need for vasopressors during hospitalization (RR= 17.32; 95% CI: 4.20 –71.36), lactate levels >2 mmol/L at diagnosis (RR=4.60; 95% CI: 1.05– 20.07) and Sequential Organ Failure
Assessment score >2 at diagnosis (RR= 5.97; 95% CI: 1.82–19.94).
Following multiple logistic regression analysis, only the need for vasopressors during hospitalization remained as a risk factor associated with death (odds ratio [OR]= 26.38; 95% CI: 5.87–118.51).
ConclusionsThe need for vasopressors during hospitalization is associated with death in obstetric patients with sepsis.
LimitationsThe analysis was performed only on one center.
The study was based on the review of medical records, the fact that some data were missing may raise doubts about the chronology of certain events.
Table 6. Results obtained by Al-Ostad et al. (2015) [19].
Table 6. Results obtained by Al-Ostad et al. (2015) [19].
PurposeEstimation of the incidence rate and mortality rate of sepsis, as well as the associated risk factors for their development during pregnancy, labor, delivery and the postpartum period.
Number
of subjects included

5 million births
Inclusion criteriaThe 1998–2008 database from the Healthcare Utilization and Cost Project, death from sepsis during admission for delivery, was used.
ResultsThe overall incidence of maternal sepsis was 29.4 per 100,000 births (95% CI: 28.0–30.9) with a sepsis case fatality rate of 4.4 per 100 births (95% CI: 3.5-5.6).
Both the incidence of maternal sepsis and the sepsis-related mortality rate have increased over the past decade.
ConclusionsMortality from maternal sepsis during labor and delivery is a growing and important problem in Westernized countries.
LimitationsThe study was limited to a single geographic area.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gorecki, G.P.; Balalau, O.D.; Comandasu, D.E.; Stanescu, A.D.; Tomescu, D.R. Best Therapeutic Practices in the Management of Obstetric Sepsis. J. Mind Med. Sci. 2023, 10, 304-311. https://doi.org/10.22543/2392-7674.1436

AMA Style

Gorecki GP, Balalau OD, Comandasu DE, Stanescu AD, Tomescu DR. Best Therapeutic Practices in the Management of Obstetric Sepsis. Journal of Mind and Medical Sciences. 2023; 10(2):304-311. https://doi.org/10.22543/2392-7674.1436

Chicago/Turabian Style

Gorecki, Gabriel Petre, Oana Denisa Balalau, Diana Elena Comandasu, Anca Daniela Stanescu, and Dana Rodica Tomescu. 2023. "Best Therapeutic Practices in the Management of Obstetric Sepsis" Journal of Mind and Medical Sciences 10, no. 2: 304-311. https://doi.org/10.22543/2392-7674.1436

APA Style

Gorecki, G. P., Balalau, O. D., Comandasu, D. E., Stanescu, A. D., & Tomescu, D. R. (2023). Best Therapeutic Practices in the Management of Obstetric Sepsis. Journal of Mind and Medical Sciences, 10(2), 304-311. https://doi.org/10.22543/2392-7674.1436

Article Metrics

Back to TopTop